Stocks and Investing Stocks and Investing
Fri, July 17, 2020

Matt Miksic Maintained (ABT) at Buy with Increased Target to $109 on, Jul 17th, 2020


Published on 2024-10-27 09:50:37 - WOPRAI, Matt Miksic
  Print publication without navigation


Matt Miksic of Credit Suisse, Maintained "Abbott Laboratories" (ABT) at Buy with Increased Target from $106 to $109 on, Jul 17th, 2020.

Matt has made no other calls on ABT in the last 4 months.



There are 6 other peers that have a rating on ABT. Out of the 6 peers that are also analyzing ABT, 0 agree with Matt's Rating of Hold.



These are the ratings of the 6 analyists that currently disagree with Matt


  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Increased Target to $122 on, Friday, July 10th, 2020
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $109 on, Friday, April 17th, 2020
  • Raj Denhoy of "Jefferies" Maintained at Strong Buy with Increased Target to $113 on, Friday, April 17th, 2020
  • Rick Wise of "Stifel" Maintained at Strong Buy with Increased Target to $108 on, Friday, April 17th, 2020
  • Jayson Bedford of "Raymond James" Maintained at Buy with Increased Target to $102 on, Friday, April 17th, 2020
  • Kevin Huang of "CFRA" Maintained at Strong Buy with Increased Target to $101 on, Thursday, April 16th, 2020
Contributing Sources